How does TRIDB's PS Ratio compare to its peers?

TRIDB is expensive based on its Price-To-Sales Ratio (10.5x) compared to the peer average (10.2x).

How does TRIDB's PS Ratio compare vs other companies in the AU Healthcare Services Industry?

TRIDB is expensive based on its Price-To-Sales Ratio (10.5x) compared to the Global Healthcare Services industry average (3.5x).

What is TRIDB's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate TRIDB's Price-To-Sales Fair Ratio for valuation analysis.

What is the Fair Price of TRIDB when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to calculate TRIDB's fair value for valuation analysis.

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

TrivarX (ASX:TRIDB) - Stock Price, News & Analysis

TRIDB Stock Overview

A health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States.

About the company

TRIDB fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	5/6
Dividends	0/6

Rewards

Earnings have grown 13.9% per year over the past 5 years

Risk Analysis

Does not have a meaningful market cap (A$10M)

Makes less than USD$1m in revenue (A$960K)

Shareholders have been substantially diluted in the past year

Shares are highly illiquid

TrivarX Limited Competitors

Global Health

ASX:GLH

AU$8.1m

Visionflex Group

ASX:VFX

AU$14.6m

Intelicare Holdings

ASX:ICR

AU$4.9m

HITIQ

ASX:HIQ

AU$9.9m

Price History & Performance

Summary of all time highs, changes and price drops for TrivarX
Historical stock prices
Current Share Price	AU$0.026
52 Week High	AU$0.029
52 Week Low	AU$0.022
Beta	0.62
11 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	18.18%

Recent updates

Shareholder Returns

	TRIDB	AU Healthcare Services	AU Market
7D	-7.1%	2.4%	0.7%
1Y	n/a	117.0%	16.7%

Return vs Industry: Insufficient data to determine how TRIDB performed against the Australian Healthcare Services industry.

Return vs Market: Insufficient data to determine how TRIDB performed against the Australian Market.

Price Volatility

Is TRIDB's price volatile compared to industry and market?
TRIDB volatility
TRIDB Average Weekly Movement	n/a
Healthcare Services Industry Average Movement	8.9%
Market Average Movement	8.5%
10% most volatile stocks in AU Market	17.2%
10% least volatile stocks in AU Market	3.5%

Stable Share Price: TRIDB has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine TRIDB's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1987	n/a	n/a	trivarx.com

TrivarX Limited, a health technology company, assists in the detection and screening of mental health conditions in Australia and the United States. The company offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. The company was formerly known as Medibio Limited and changed its name to TrivarX Limited in October 2023.

TrivarX Limited Fundamentals Summary

How do TrivarX's earnings and revenue compare to its market cap?
TRIDB fundamental statistics
Market cap	AU$10.07m
Earnings (TTM)	-AU$3.07m
Revenue (TTM)	AU$960.45k

10.5x

P/S Ratio

-3.3x

P/E Ratio

Is TRIDB overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
TRIDB income statement (TTM)
Revenue	AU$960.45k
Cost of Revenue	AU$158.00
Gross Profit	AU$960.29k
Other Expenses	AU$4.03m
Earnings	-AU$3.07m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)	-0.0091
Gross Margin	99.98%
Net Profit Margin	-319.70%
Debt/Equity Ratio	0%

How did TRIDB perform over the long term?

See historical performance and comparison

TrivarX ASX:TRIDB Stock Report